Necrotising Fasciitis
Infection Necrotising fasciitis Brief outline/clinical setting Life-threatening, invasive, rapidly progressive soft-tissue infection with a necrotising component involving the deeper fascia. Characteristics associated with increased likelihood of necrotizing infection: - Oedema - Erythema - Severe and crescendo pain out of proportion - Cutaneous anaesthesia - Skin bullae or necrosis (at lat
| Infection | Necrotising fasciitis |
| Brief outline/clinical setting |
Life-threatening, invasive, rapidly progressive soft-tissue infection with a necrotising component involving the deeper fascia. Characteristics associated with increased likelihood of necrotizing infection: |
| Aetiologies/organisms | Monomicrobial: Group A streptococci, S. aureus, Aeromonas hydrophila, Vibrio vulnificus, anaerobic streptococci Polymicrobial: mixed anaerobes (e.g. Clostridium perfringens) and aerobic gram negative organisms, mostly originating from the bowel or genitourinary flora |
| Optimal antimicrobial selection | Piperacillin-tazobactam 4.5g 8 hourly IVI (PLUS antibiotic that inhibit toxin production if S.pyogenes implicated e.g. clindamycin 600mg 8 hourly IVI) |
| Duration | Antibiotic therapy should be administered until further debridement is no longer necessary, the patient has improved clinically, and fever has resolved for 48–72 h |
| Alternative if allergic/not available | Ciprofloxacin 400mg 8 hourly IVI PLUS metronidazole 500mg 8 hourly IVI PLUS vancomycin (loading dose 20-30mg/kg, followed by 15-20mg/kg; maintain trough levels at 15–20mg/mL) |
| Rationale | The use of antimicrobial therapy is an adjuvant treatment and must be combined with early surgical debridement (every 24h – 48h) |
| Level of evidence | Guidelines (Strong recommendation, moderate-quality) evidence |
| Link to Guideline | Click here |